Please use this identifier to cite or link to this item:
Title: Remarkable NIR enhancement of multifunctional nanoprobes for in vivo trimodal bioimaging and upconversion optical/T2-weighted MRI-guided small tumor diagnosis
Authors: Yi, Z
Li, X
Xue, Z
Liang, X
Lu, W
Peng, H
Liu, H
Zeng, S
Hao, J
Keywords: Biodistribution
Enhanced near-infrared emission
Trimodal bioimaging
Tumor detection
Upconversion nanoparticles
Issue Date: 2015
Publisher: Wiley-VCH
Source: Advanced functional materials, 2015, v. 25, no. 46, p. 7119-7129 How to cite?
Journal: Advanced functional materials 
Abstract: Effective nanoprobes and contrast agents are urgently sought for early-stage cancer diagnosis. Upconversion nanoparticles (UCNPs) are considerable alternatives for bioimaging, cancer diagnosis, and therapy. Yb3+/Tm3+ co-doping brings both emission and excitation wavelengths into the near-infrared (NIR) region, which is known as "optical transmission window" and ideally suitable for bioimaging. Here, NIR emission intensity is remarkably enhanced by 113 times with the increase of Yb3+ concentration from 20% to 98% in polyethylene glycol (PEG) modified NaYF4:Yb3+/Tm3+ UCNPs. PEG-UCNPs-5 (98% Yb3+) can act as excellent nanoprobes and contrast agents for trimodal upconversion (UC) optical/CT/T2-weighted magnetic resonance imaging (MRI). In addition, the enhanced detection of lung in vivo long-lasting tracking, as well as possible clearance mechanism and excretion routes of PEG-UCNPs-5 have been demonstrated. More significantly, a small tumor down to 4 mm is detected in vivo via intravenous injection of these nanoprobes under both UC optical and T2-weighted MRI modalities. PEG-UCNPs-5 can emerge as bioprobes for multi-modal bioimaging, disease diagnosis, and therapy, especially the early-stage tumor diagnosis. A remarkable enhancement of NIR emission of multifunctional PEGylated upconversion nanoparticles (UCNPs) is developed. The nanoparticles serve as bioprobes and contrast agents for upconversion (UC) optical, magnetic resonance imaging (MRI), and CT trimodal bioimaging. Impressively, the developed UCNPs are successfully used for UC and T2-weighted MRI-guided early-stage diagnosis of small tumors.
ISSN: 1616-301X
DOI: 10.1002/adfm.201503672
Appears in Collections:Journal/Magazine Article

View full-text via PolyU eLinks SFX Query
Show full item record


Last Week
Last month
Citations as of Dec 7, 2018


Last Week
Last month
Citations as of Dec 10, 2018

Page view(s)

Last Week
Last month
Citations as of Dec 10, 2018

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.